HK1224227A1 - 含有人參皂苷成分得到增加的加工人參粉沫或加工人參提取物的用於預防及治療癌因性疲乏的組合物 - Google Patents

含有人參皂苷成分得到增加的加工人參粉沫或加工人參提取物的用於預防及治療癌因性疲乏的組合物

Info

Publication number
HK1224227A1
HK1224227A1 HK16112694.6A HK16112694A HK1224227A1 HK 1224227 A1 HK1224227 A1 HK 1224227A1 HK 16112694 A HK16112694 A HK 16112694A HK 1224227 A1 HK1224227 A1 HK 1224227A1
Authority
HK
Hong Kong
Prior art keywords
processed ginseng
constituent
preventing
composition
treating cancer
Prior art date
Application number
HK16112694.6A
Other languages
English (en)
Inventor
劉泳孝
金點溶
金珠英
朴宣奎
Original Assignee
Green Cross Wellbeing Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Wellbeing Corp filed Critical Green Cross Wellbeing Corp
Publication of HK1224227A1 publication Critical patent/HK1224227A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/20—Preparation of steroids containing heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HK16112694.6A 2013-08-30 2016-11-03 含有人參皂苷成分得到增加的加工人參粉沫或加工人參提取物的用於預防及治療癌因性疲乏的組合物 HK1224227A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2013/007852 WO2015030283A1 (ko) 2013-08-30 2013-08-30 진세노사이드 성분이 증가된 가공인삼분말 또는 가공인삼추출물을 함유하는 암 관련 피로의 예방 및 치료용 조성물

Publications (1)

Publication Number Publication Date
HK1224227A1 true HK1224227A1 (zh) 2017-08-18

Family

ID=52586820

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112694.6A HK1224227A1 (zh) 2013-08-30 2016-11-03 含有人參皂苷成分得到增加的加工人參粉沫或加工人參提取物的用於預防及治療癌因性疲乏的組合物

Country Status (9)

Country Link
US (2) US10709749B2 (zh)
EP (2) EP3040078B1 (zh)
JP (1) JP6435333B2 (zh)
KR (1) KR101595426B1 (zh)
CN (2) CN111437297A (zh)
ES (1) ES2871381T3 (zh)
HK (1) HK1224227A1 (zh)
PL (1) PL3040078T3 (zh)
WO (1) WO2015030283A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101917794B1 (ko) 2018-05-10 2018-11-13 한국과학기술원 진세노사이드 Rh2를 포함하는 근육 질환 개선, 예방 또는 치료용 조성물
KR101966117B1 (ko) 2018-05-25 2019-04-05 (주)녹십자웰빙 가공인삼추출물을 포함하는 근육 분화 촉진용 조성물
KR20200089370A (ko) 2019-01-16 2020-07-27 신라대학교 산학협력단 새싹삼 건조분말을 유효성분으로 포함하는 고추장 및 이의 제조방법
KR102017282B1 (ko) 2019-01-28 2019-09-02 (주)녹십자웰빙 가공인삼추출물을 포함하는 근육 분화 촉진용 조성물
KR102095536B1 (ko) 2019-06-04 2020-03-31 (주)녹십자웰빙 천연물 추출물의 용출률 및 붕해성이 개선된 경구용 제제
CN112852621B (zh) * 2021-01-21 2021-09-14 伽能生物科技(上海)有限公司 人参酵素的生产集成系统、利用其进行人参酵素生产的方法、人参酵素及其应用
CN113940952A (zh) * 2021-11-25 2022-01-18 瑞莱茵(北京)生物科技有限责任公司 人参发酵提取物及其制备方法
CN114181275A (zh) * 2021-12-29 2022-03-15 水羊化妆品制造有限公司 一种人参皂苷Rg3、其制备方法及其用途
KR102539303B1 (ko) * 2022-12-22 2023-06-02 건인약품 주식회사 체력회복을 위한 한방 기능성 식품 및 그의 제조방법

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6312300A (ja) 1985-07-22 1988-01-19 Takeda Chem Ind Ltd ジンセノサイド−Ｒｄの製造法
JPH03277246A (ja) 1990-03-27 1991-12-09 Morinaga & Co Ltd 薬用ニンジンを用いた新規な食用素材の製造法
FR2663225B1 (fr) 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
JP3160313B2 (ja) 1991-07-01 2001-04-25 勲 北川 制癌剤
FR2684875B1 (fr) 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
DE59310216D1 (de) 1992-11-27 2001-10-25 Aventis Res & Tech Gmbh & Co Heterogenes Proteingemisch mit alpha-L-rhamnosidase Aktivität, Verfahren zu ihrer Herstellung und ihre Verwendung.
FR2706767B1 (zh) 1993-06-22 1995-09-08 Lafon Labor
JPH08291194A (ja) 1995-04-18 1996-11-05 Happy World:Kk ニンジンサポゲニン及びその製造法
JPH1014523A (ja) 1996-07-08 1998-01-20 Nagaoka Jitsugyo Kk 高麗人参加工食品およびその製造方法
JPH1099094A (ja) 1996-09-25 1998-04-21 Happy World:Kk 薬用ニンジンサポニン代謝産物の製造法
KR100293968B1 (ko) 1998-12-30 2001-09-17 박명규 20(에스)-진세노사이드알에이취투의제조방법
CN1105781C (zh) 1999-03-17 2003-04-16 金凤燮 酶法改变人参皂甙糖基制备人参皂甙的方法
US9387168B2 (en) * 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
EP1354944B1 (en) 2000-12-29 2008-11-19 Fengxie Jin Ginsenoside glycosidase which hydrolyzes ginsenoside glycosyl and the use thereof
JP2002348245A (ja) 2001-05-07 2002-12-04 Toyo Hakko:Kk 紅参有効成分の低分子化方法、抗酸化飲料及びその製造方法
US6888014B2 (en) 2001-07-24 2005-05-03 Panagin Pharmaceuticals Inc. Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
US20030092638A1 (en) 2001-09-21 2003-05-15 Dong Huang Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
JP2003160497A (ja) 2001-11-22 2003-06-03 Toshin Kagaku Kk 皮膚外用剤
KR100425022B1 (ko) * 2002-01-05 2004-03-27 롯데제과주식회사 가공인삼 추출물 및 이를 함유하는 약제 조성물
US20030185910A1 (en) 2002-02-08 2003-10-02 Taik Koo Yun Cancer preventive composition comprising ginsenoside glycosides of red ginseng
AU2003202159A1 (en) 2002-04-08 2003-10-27 Ginseng Science Inc. Extract of processed panax genus plant, the preparation method thereof, and compositions containing the same
WO2003088986A1 (en) * 2002-04-16 2003-10-30 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage
CA2390290A1 (en) * 2002-06-11 2003-12-11 Panagin Pharmaceuticals Inc. Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
EP1519733A1 (en) 2002-06-11 2005-04-06 Panagin Pharmaceuticals Inc. Compositions for cancer therapy comprising saponins or sapogenins
WO2004004748A1 (ja) * 2002-07-02 2004-01-15 Kyowa Engineering Co., Ltd. 癌の誘発または癌の転移を予防するカワリハラタケ抽出物
KR100497895B1 (ko) * 2002-12-05 2005-06-29 홍림통산(주) 인삼의 유산균 발효물, 그를 함유하는 인삼 요구르트 및그에 이용되는 유산균 균주
CN1477205A (zh) 2003-07-10 2004-02-25 黄亚平 生物催化剂转化人参皂甙生产稀有人参皂甙的方法
WO2005030235A1 (ja) 2003-09-30 2005-04-07 Wakunaga Pharmaceutical Co., Ltd. 薬用人参の加工方法及び組成物
WO2005034963A1 (en) 2003-10-15 2005-04-21 Panagin Pharmaceuticals Inc. USE OF GINSENOSIDES Rh2 & Rg3, AND AGLYCON GINSENOSIDES FOR THE PREVENTION OF CANCER
KR20050053048A (ko) 2003-12-02 2005-06-08 주식회사 동원고려인삼 진세노사이드 알지3가 다량 함유된 홍삼 엑기스의 제조방법
KR100789261B1 (ko) 2004-12-28 2007-12-31 김재백 배당체 분해물을 함유하는 발효인삼 및 이의 제조방법
KR100789678B1 (ko) 2005-10-07 2008-01-02 (주)예당바이오 김치 유산균을 이용한 발효인삼 또는 발효홍삼의 제조방법
CN1981776B (zh) 2005-12-15 2013-03-13 昆明维泰尔健康科技有限责任公司 含稀有人参皂甙的组合物及其制备方法以及用途
CN100423727C (zh) 2006-01-19 2008-10-08 云南天秀植物科技开发有限公司 一种抗肿瘤的药物组合物及其制备工艺
CN1883492B (zh) * 2006-05-22 2010-07-28 富力 20(R)-人参皂苷Rg3药用组合物水溶液及制备方法
US20080113043A1 (en) 2006-10-18 2008-05-15 In-Hwan Seong Method for producing ginseng fruit and ginseng flower stalk with high content of ginsenoside
KR100805852B1 (ko) 2006-12-21 2008-02-21 한국식품연구원 진세노사이드가 강화된 인삼을 제조하는 방법 및 이를이용한 홍삼의 제조방법
JP5271534B2 (ja) 2006-12-25 2013-08-21 ライオン株式会社 筋萎縮抑制剤
KR101082181B1 (ko) * 2007-05-31 2011-11-09 박용진 신규한 흑홍삼 및 이의 추출물의 제조방법 및 이를 함유하는 조성물
JP5204771B2 (ja) 2007-06-21 2013-06-05 長瀬産業株式会社 Ｇａｂａ作動性ニューロン賦活剤
WO2008155998A1 (ja) 2007-06-21 2008-12-24 Nagase & Co., Ltd. 抗不安抗うつ剤
KR20090037140A (ko) 2007-10-11 2009-04-15 메타볼랩(주) 진세노사이드의 화합물 ｋ로의 전환방법
AU2009216012A1 (en) 2008-02-19 2009-08-27 Unigen, Inc. Leaves extract of panax SP., a process of making the same and uses thereof
CN101612159B (zh) 2008-06-23 2011-08-31 上海药谷药业有限公司 化合物20(S)-人参皂苷Rh2在制备抗疲劳药物中的应用
JP2010132625A (ja) 2008-12-08 2010-06-17 Nagase & Co Ltd 抗糖尿病剤
KR101120996B1 (ko) 2009-10-09 2012-03-13 대동고려삼 주식회사 진세노사이드 Ｒｇ３ 및 Ｒｇ２를 포함하는 운동능력증진 및 피로회복 증진용 조성물
KR101382114B1 (ko) * 2009-11-30 2014-04-08 (주)아모레퍼시픽 홍삼 다당체 추출물을 함유하는 피부 외용제 조성물
KR100992800B1 (ko) * 2010-05-14 2010-11-08 주식회사 지씨에이치앤피 미량의 진세노사이드 성분이 증가된 신규한 가공인삼 또는 가공인삼추출물의 제조방법
US8588787B2 (en) * 2010-05-28 2013-11-19 Sumitomo Electric Industries, Ltd. Neighboring cell processing device, wireless base station device, neighboring cell processing method and data structure
KR101400782B1 (ko) * 2012-02-14 2014-05-29 한국과학기술연구원 진세노사이드 ２０(ｓ)-알지3 또는 진세노사이드 ２０(ｒ)-알지3의 함량비율이 증가된 가공 파낙스속 식물 추출물, 그 제조방법, 및 그 가공 파낙스속 식물 추출물을 포함하는 조성물
KR101493413B1 (ko) * 2012-06-27 2015-02-16 주식회사 녹십자에이치에스 진세노사이드 알지3 및 알에이치2를 유효성분으로 하는 인삼 또는 홍삼의 가공물을 함유하는 간섬유증 또는 간경화증의 치료 또는 예방용 조성물
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica

Also Published As

Publication number Publication date
PL3040078T3 (pl) 2021-11-02
KR101595426B1 (ko) 2016-02-18
ES2871381T3 (es) 2021-10-28
EP3854409A1 (en) 2021-07-28
WO2015030283A1 (ko) 2015-03-05
US20200297789A1 (en) 2020-09-24
CN105658227A (zh) 2016-06-08
EP3040078A1 (en) 2016-07-06
US11464821B2 (en) 2022-10-11
KR20150095708A (ko) 2015-08-21
EP3040078A4 (en) 2017-05-31
US10709749B2 (en) 2020-07-14
CN105658227B (zh) 2020-04-03
US20160213723A1 (en) 2016-07-28
JP2016530281A (ja) 2016-09-29
CN111437297A (zh) 2020-07-24
JP6435333B2 (ja) 2018-12-05
EP3040078B1 (en) 2021-02-24

Similar Documents

Publication Publication Date Title
HK1224227A1 (zh) 含有人參皂苷成分得到增加的加工人參粉沫或加工人參提取物的用於預防及治療癌因性疲乏的組合物
HK1215378A1 (zh) 藥物組合物、治療方法及其用途
IL304820A (en) Preparations and methods for the treatment of cancer
PT3377516T (pt) Composição para o tratamento do cancro
EP2815746A4 (en) SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF
EP2861256A4 (en) COMPOSITIONS FOR THE TREATMENT OF CANCER AND METHODS FOR PREPARING THE SAME
EP2818483A4 (en) MEDICINAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
HK1255815A1 (zh) 治療腹膜癌的組合物和方法
IL256523A (en) Compositions and methods for treating cancer
IL241823B (en) Preparations containing novyi .c and their uses for the treatment of cancerous tumors
EP3012292A4 (en) TREATMENT ADJUVANT, AND COMPOSITION
EP2990047A4 (en) COMPOSITION FOR PREVENTING, RELIEVING OR TREATING COLITIS CONTAINING COMPLEX EXTRACTS
IL245296A0 (en) Herbal composition, process for its preparation and use
PT3391893T (pt) Composição farmacêutica para o tratamento da leucemia e método de preparação da mesma
IL255638A (en) Compositions and methods for treating cancer
HK1256167A1 (zh) 用於治療或預防癌症和神經疾病的包括15-hepe的組合物
IL259358A (en) Bis-pyridazine compounds and their use in treating cancer
EP3495324A4 (en) ZINCOXIDE COMPOSITE PARTICLES, COMPOSITION FOR UV SHIELDING AND COSMETIC
PL3290051T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
IL258512B (en) Methods and preparations for the prevention or treatment of cancer
SG11201510700VA (en) Metal-containing particles, processes for their preparation, and uses thereof
HUE040589T2 (hu) Finomszemcsés fehérítõ katalizátor, eljárás ennek elõállítására és ennek alkalmazása
ZA201904626B (en) Cancer treatment method and composition
HK1250496B (zh) 一種粉末化妝品組合物、用途及其製備方法
HK1250958A1 (zh) 用於治療癌症的組合物和方法